top of page

How Pomegranate Juice Dramatically Reversed Arterial Plaque in Landmark Study



Could a simple fruit hold the key to reversing heart disease? A groundbreaking study from 2004 suggests that pomegranate juice may possess unparalleled potential in the fight against atherosclerosis, yet this natural solution has been largely ignored by the medical establishment


In the face of an epidemic of heart disease, the search for effective preventive solutions has never been more urgent. While pharmaceutical therapies dominate the landscape of cardiology, a groundbreaking study from 2004 suggests that a natural approach--drinking pomegranate juice--may hold the key to combating atherosclerosis, the buildup of plaque in the arteries that underlies many forms of cardiovascular disease.


The study, led by Dr. Michael Aviram and published in the journal Clinical Nutrition, followed 19 patients with severe carotid artery stenosis, a narrowing of the arteries that supply blood to the brain.1 Ten of these patients consumed 50mL of pomegranate juice daily, while the other nine served as a control group. The results were nothing short of remarkable: after one year, the pomegranate group experienced a significant reduction in the thickness of their carotid artery walls, a key measure of atherosclerosis progression.1


Even more strikingly, five patients continued drinking pomegranate juice for a total of three years, and the benefits only increased with time. Carotid intima-media thickness (IMT), a measure of arterial wall thickening, decreased by 35% after one year and remained reduced for the duration of the study.1 In contrast, IMT increased by 9% in the control group over the same period.1


So how does this unassuming fruit wield such power against a formidable disease? The answer lies in its unrivaled antioxidant content. Pomegranates are rich in polyphenols, tannins, and anthocyanins, all of which scavenge the free radicals that contribute to oxidative stress and inflammation in the body.2 This is critical because oxidized low-density lipoprotein (LDL) cholesterol is a key player in the development of atherosclerosis.3


Indeed, the study found that pomegranate juice consumption reduced oxidative stress markers and increased antioxidant capacity in the participants' blood. Serum levels of antibodies against oxidized LDL decreased by 19%, while total antioxidant status increased by 130% after one year of daily pomegranate intake.1 The juice also boosted the activity of paraoxonase, an enzyme that protects against LDL oxidation, by up to 83%.1


But the benefits didn't stop there. Pomegranate juice appeared to reduce blood pressure as well, with systolic blood pressure decreasing by 21% after one year.1 This is likely due to the juice's ability to improve endothelial function and reduce oxidative stress in the blood vessels.4


Perhaps most intriguing of all, the study examined carotid artery plaque specimens from two patients who had consumed pomegranate juice before undergoing surgery. Compared to plaques from control patients, these specimens showed significantly lower levels of oxidized lipids and higher antioxidant content, suggesting that pomegranate juice may directly impact the atherosclerotic lesions themselves.1


The implications of these findings are profound. While current medical therapies focus primarily on risk factor management, such as surrogate measures like lowering cholesterol and blood pressure, pomegranate juice appears to target the root cause of atherosclerosis by reducing oxidative stress and inflammation, and healing the underlying damage to the endothelium and arteries. And unlike many pharmaceutical drugs, it is a safe and well-tolerated food, and accessible to virtually everyone.


Yet despite the extraordinary results of this study, pomegranate juice has not been widely embraced as a therapeutic option by the medical community. This raises questions about a potential bias against natural remedies, even when they are supported by rigorous scientific evidence. If a drug showed similar effects on atherosclerosis, it would undoubtedly be hailed as a major breakthrough and rapidly incorporated into standard treatment protocols.


The time has come for a paradigm shift in our approach to heart disease prevention and treatment. While pharmaceuticals certainly have their place, we cannot afford to overlook the immense potential of natural therapies like pomegranate juice. With millions of lives at stake, it is imperative that we prioritize further research into this remarkable fruit and its cardiovascular benefits.


In the meantime, the message to patients is clear: incorporating pomegranate juice into a heart-healthy lifestyle may offer a safe, effective, and delicious way to protect against atherosclerosis and its devastating consequences. As we continue to unravel the mysteries of this ancient fruit, one thing is certain--the humble pomegranate may just hold the key to a brighter, healthier future for us all.


Learn more about the health benefits of pomegranate here.


Learn more about natural approaches to addressing atherosclerosis plaque here.



References


1. Aviram, Michael, Mira Rosenblat, Diana Gaitini, Samy Nitecki, Aaron Hoffman, Leslie Dornfeld, Nina Volkova, et al. "Pomegranate Juice Consumption for 3 Years by Patients with Carotid Artery Stenosis Reduces Common Carotid Intima-Media Thickness, Blood Pressure and LDL Oxidation." Clinical Nutrition 23, no. 3 (June 2004): 423-33. https://doi.org/10.1016/j.clnu.2003.10.002.


2. Gil, M. I., F. A. Tomás-Barberán, B. Hess-Pierce, D. M. Holcroft, and A. A. Kader. "Antioxidant Activity of Pomegranate Juice and Its Relationship with Phenolic Composition and Processing." Journal of Agricultural and Food Chemistry 48, no. 10 (October 2000): 4581-89. https://doi.org/10.1021/jf000404a.


3. Aviram, Michael. "Review of Human Studies on Oxidative Damage and Antioxidant Protection Related to Cardiovascular Diseases." Free Radical Research 33 Suppl (2000): S85-97. https://pubmed.ncbi.nlm.nih.gov/11191279/


4. Aviram, M., and L. Dornfeld. "Pomegranate Juice Consumption Inhibits Serum Angiotensin Converting Enzyme Activity and Reduces Systolic Blood Pressure." Atherosclerosis 158, no. 1 (September 2001): 195-98. https://doi.org/10.1016/s0021-9150(01)00412-9.

Kommentarer


bottom of page